"10.1371_journal.pone.0112313","plos one","2014-11-11T00:00:00Z","Matthieu Legrand; Benedetta De Berardinis; Hanna K Gaggin; Laura Magrini; Arianna Belcher; Benedetta Zancla; Alexandra Femia; Mandy Simon; Shweta Motiwala; Rasika Sambhare; Salvatore Di Somma; Alexandre Mebazaa; Vishal S Vaidya; James L Januzzi; from the Global Research on Acute Conditions Team (GREAT)","AP-HP, Groupe hospitalier St-Louis-Lariboisi√®re, Department of Anesthesiology and Critical Care and Burn unit, F-75475, Paris, France; Univ Paris Diderot, Paris, France; U942 Inserm F-75475, Paris, France; Emergency Medicine, Department of Medical-Surgery Sciences and Translational Medicine, University Sapienza Rome, SantAndrea Hospital, Roma, Italy; Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States of America; Harvard Medical School and Harvard School of Public Health, Boston, MA, United States of America","Conceived and designed the experiments: ML SDS AM JLJ. Performed the experiments: BDB HKG LM AB BZ AF MS SM RS. Analyzed the data: ML VSV JLJ. Contributed reagents/materials/analysis tools: SDS AM JLJ. Contributed to the writing of the manuscript: ML AM JLJ.","The authors have read the journals policy and the authors of this manuscript have the following competing interests: Dr. Legrand consulted for Alere (lecture fees) and received support for research from Astute, bioporto and BRAHMS. Dr. Mebazaa served as board member for Critical Diagnostics, The Medicine Company, Cardiorentis, and Bayer and lectured for Alere, Bayer, Edwards Life Sciences, The Medicines Company, Novartis, Orion, Servier, Thermofisher, and Vifor Pharma. Dr. Januzzi received support for participation in review activities from Radiometer. His institution received grant support from Roche Diagnostics, Siemens, Critical Diagnostics, BG Medicine, Singulex, and Thermo Fisher. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","11","Matthieu Legrand","ML",15,TRUE,4,9,3,NA,TRUE,TRUE,TRUE,1,"15",TRUE
